A summary of my research on the #Sinopharm inactivated virus vaccine aka *BBIBP-CorV*
π 1st report describing technology and immunogenicity / safety in primates bit.ly/3dVWx1D (π§΅)
π 2nd report with Phase I/II results - 100% seroconversion, but missing phase II data for >60 group
(π§΅) bit.ly/2Qhqm4A
π Several Phase III trials started last summer and later, but no released data yet. 86% efficacy reported from Phase III interim data from UEA Dec 2020, but only via press release (no data shown) (π§΅) reut.rs/3225gJZ bit.ly/2Q7pWgV bit.ly/3a0gK54
πA pre-print (not peer-reviewed) indicates that BBIBP-CorV remains efficacious against the South African (B.1.351) strain (which would be great news if confirmed) (π§΅) bit.ly/3d5WNvs
An excellent review with summaries on #Sinopharm and other vaccine candidates that are in Phase III trials at the moment. The future seems bright (the end) bit.ly/3a06t91
Thanks to the @CEPIvaccines@WHO@EuWHOEurope#Covax and others, 24,000 doses of #AstraZeneca vaccines arrived in π²πͺ last week, and this is just fantastic! But as in other European countries, there is a lot of hesitancy and fear related to this vaccine. ππ» (π§΅)
The ministry of health @MinZdravlja made the #AstraZeneca vaccine available to all 65+ old citizens, and this is great news as they are the most vulnerable group that was not eligible for @sputnikvaccine and #Sinopharm vaccines given in previous weeks to people 70+ ππ»
The main fear from what I understand is related to the inconsistent recommendations about the appropriate target groups and recent reports of #thrombotic events recorded in several EU countries now. Letβs address the issues one by one ππ»
Following some hoopla that my tweet ππ» causedβ¦
1. I want to applaud all the medical workers in #Montenegro - epidemiologists, support staff, technicians, nurses, doctors - who are at the front line, caring for the many sick people in the hospitals around the country (π§΅1/10)
I want to make sure that what Iβll say is #not meant to indicate that the #services you provide in π²πͺ are not good - I know that you are doing your very best, and I thank you from the bottom of my heart (2/10)
*reminder: health services is not a synonym for health system
My comment that it doesnβt make sense to use #CFR (or as was referred to βlethalityβ) for comparisons between countries, and as a mirror of the quality of health system quality is based on the following facts (3/10)
The main findings are discussed in the 𧡠that follows (1/n)
KSHV and its cousin EBV use an envelope glycoprotein complex called gH/gL to bind to #EphA2 receptor tyrosine kinase to gain access to host cells. We set to determine the structure of the KSHV gH/gL-EphA2 complex and perform functional studies to understand the mechanism (2/n)
While we were gathering the functional data Su et al. published the 3.2 A structure and provided some interesting insights few months ago.
But under our 'no scoop good enough' mantra we kept working and obtained some cool data that we can now share (3/n)
Seemingly good news are coming from π²πͺ and this makes me happy, but I implore @VladaCG not to give false idea of security to its citizens. The number of detected cases dropped by 50% as their graph shows, but that is largely due to the β¬οΈ numbers of tested performed daily. (1/4)
If you look at the incidence rate, it shows a very small decrease that cannot be reliably attributed to 'a better situation' in #Montenegro (2/4)
Don't be fooled that the situation will get better until most people are vaccinated. The B.1.1.7 (UK) strain that is wracking havoc around Europe now is growing in Montenegro too, it's just that we don't know which % it is at now because of the lack of sequencing (3/4)